A. Sud

Most-cited papers

1. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

   A. Sud, Michael Jones, J. Broggio, C. Loveday +19 more

   2020Annals of Oncology467 citations Open access

   Semantic Scholar

   Save

2. Effect of delays in the UK two-week wait cancer referral pathway during the COVID-19 pandemic on cancer survival: a modelling study

   A. Sud, B. Torr, Michael E. Jones, J. Broggio +19 more

   2020The Lancet Oncology420 citations Open access

   Semantic Scholar

   Save

3. Genome-wide association studies of cancer: current insights and future perspectives

   A. Sud, B. Kinnersley, R. Houlston

   2017Nature Reviews. Cancer351 citations

   Semantic Scholar

   Save

4. Association analyses identify 31 new risk loci for colorectal cancer susceptibility

   P. Law, Maria Timofeeva, C. Fernández-Rozadilla, P. Broderick +155 more

   2019Nature Communications205 citations Open access

   Semantic Scholar

   Save

5. Cancer genetics, precision prevention and a call to action

   C. Turnbull, A. Sud, R. Houlston

   2018Nature Genetics119 citations Open access

   Semantic Scholar

   Save

6. Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma

   S. Bird, Aikaterini Panopoulou, Robyn L. Shea, Micky Tsui +11 more

   2021The Lancet Haematology118 citations Open access

   Semantic Scholar

   Save

7. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

   M. Went, A. Sud, A. Försti, Britta Halvarsson +127 more

   2018Nature Communications108 citations Open access

   Semantic Scholar

   Save

8. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer

   H. Rodriguez-Broadbent, P. Law, A. Sud, Kimmo Palin +52 more

   2017International Journal of Cancer95 citations Open access

   Semantic Scholar

   Save

9. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History

   A. Sud, H. Thomsen, K. Sundquist, R. Houlston +1 more

   2017Journal of Clinical Oncology78 citations Open access

   Semantic Scholar

   Save

10. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.

    C. Huntley, B. Torr, A. Sud, Charlie F. Rowlands +11 more

    2023The Lancet Oncology77 citations Open access

    Semantic Scholar

    Save

11. Pro-inflammatory fatty acid profile and colorectal cancer risk : A Mendelian randomisation analysis

    S. May-Wilson, A. Sud, P. Law, Kimmo Palin +13 more

    201777 citations

    Semantic Scholar

    Save

12. Realistic expectations are key to realising the benefits of polygenic scores

    A. Sud, Rachel H. Horton, A. Hingorani, I. Tzoulaki +3 more

    2023British medical journal67 citations Open access

    Semantic Scholar

    Save

13. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study

    C. Loveday, A. Sud, Michael E. Jones, J. Broggio +18 more

    2020Gut67 citations Open access

    Semantic Scholar

    Save

14. Analysis of 153,115 patients with hematological malignancies refines the spectrum of familial risk.

    A. Sud, S. Chattopadhyay, H. Thomsen, K. Sundquist +3 more

    2019Blood64 citations Open access

    Semantic Scholar

    Save

15. The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.

    D. Hanson, P. Murray, A. Sud, S. Temtamy +9 more

    2009American Journal of Human Genetics60 citations Open access

    Semantic Scholar

    Save

16. T-cell Prolymphocytic Leukemia.

    A. Sud, C. Dearden

    2017Hematology/Oncology Clinics of North America52 citations

    Semantic Scholar

    Save

17. Will polygenic risk scores for cancer ever be clinically useful?

    A. Sud, C. Turnbull, R. Houlston

    2021npj Precision Oncology51 citations Open access

    Semantic Scholar

    Save

18. Epidemiology, genetics and treatment of multiple myeloma and precursor diseases

    K. Hemminki, A. Försti, R. Houlston, A. Sud

    2021International Journal of Cancer51 citations Open access

    Semantic Scholar

    Save

19. Impact of atopy on risk of glioma: a Mendelian randomisation study

    Linden Disney-Hogg, A. Cornish, A. Sud, P. Law +27 more

    2018BMC Medicine51 citations Open access

    Semantic Scholar

    Save

20. Collateral damage: the impact on cancer outcomes of the COVID-19pandemic

    A. Sud, Michael P. Jones, J. Broggio, C. Loveday +18 more

    2020medRxiv46 citations Open access

    Semantic Scholar

    Save

21. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci

    P. Law, A. Sud, J. Mitchell, M. Henrion +37 more

    2017Scientific Reports44 citations Open access

    Semantic Scholar

    Save

22. Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

    A. Sud, H. Thomsen, P. Law, A. Försti +87 more

    2017Nature Communications44 citations Open access

    Semantic Scholar

    Save

23. Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

    A. Sud, S. Chattopadhyay, H. Thomsen, K. Sundquist +3 more

    2018Blood42 citations Open access

    Semantic Scholar

    Save

24. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia

    G. Zheng, S. Chattopadhyay, A. Sud, K. Sundquist +5 more

    2019British Journal of Haematology41 citations Open access

    Semantic Scholar

    Save

25. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

    A. Schmidt, M. Holmes, D. Preiss, D. Swerdlow +163 more

    2018bioRxiv39 citations Open access

    Semantic Scholar

    Save

26. Influence of obesity-related risk factors in the aetiology of glioma

    Linden Disney-Hogg, A. Sud, P. Law, A. Cornish +26 more

    2018British Journal of Cancer37 citations Open access

    Semantic Scholar

    Save

27. Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis

    S. May-Wilson, A. Sud, P. Law, Kimmo Palin +50 more

    2017European Journal of Cancer37 citations Open access

    Semantic Scholar

    Save

28. Mendelian randomization provides support for obesity as a risk factor for meningioma

    Hannah Takahashi, A. Cornish, A. Sud, P. Law +18 more

    2019Scientific Reports36 citations Open access

    Semantic Scholar

    Save

29. A novel laccase from newly isolated Cotylidia pannosa and its application in decolorization of synthetic dyes

    D. Sharma, G. Goel, A. Sud, R. Chauhan

    201529 citations

    Semantic Scholar

    Save

30. Second primary cancers in non‐Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction

    S. Chattopadhyay, A. Sud, G. Zheng, Hongyao Yu +6 more

    2018International Journal of Cancer27 citations Open access

    Semantic Scholar

    Save

31. Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.

    A. Sud, H. Thomsen, Giulia Orlando, A. Försti +24 more

    2018Blood27 citations Open access

    Semantic Scholar

    Save

32. Survival trends in hematological malignancies in the Nordic countries through 50 years

    K. Hemminki, Janne Hemminki, A. Försti, A. Sud

    2022Blood Cancer Journal26 citations Open access

    Semantic Scholar

    Save

33. Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology

    M. Went, A. Sud, H. Speedy, N. Sunter +51 more

    2018Blood Cancer Journal26 citations Open access

    Semantic Scholar

    Save

34. Second primary cancers in non‐Hodgkin lymphoma: Family history and survival

    S. Chattopadhyay, G. Zheng, A. Sud, K. Sundquist +5 more

    2019International Journal of Cancer24 citations

    Semantic Scholar

    Save

35. Mendelian randomisation study of the relationship between vitamin D and risk of glioma

    Hannah Takahashi, A. Cornish, A. Sud, P. Law +27 more

    2018Scientific Reports24 citations Open access

    Semantic Scholar

    Save

36. Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden.

    S. Chattopadhyay, G. Zheng, A. Sud, Hongyao Yu +6 more

    2018The Lancet Haematology22 citations

    Semantic Scholar

    Save

37. Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism

    Ni Li, David C. Johnson, N. Weinhold, Scott Kimber +20 more

    2017Cell Reports22 citations Open access

    Semantic Scholar

    Save

38. Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019

    Tom P. Rory Phillip L. R. Andrew J. Rebecca J. Alexand Bull McCulloch Nicolson Doyle Shaw Langridge Sayar, Tom Bull, R. McCulloch, P. Nicolson +142 more

    2022Journal of Thrombosis and Haemostasis20 citations Open access

    Semantic Scholar

    Save

39. Candidate gene association studies and risk of Hodgkin Lymphoma: a systematic review and meta-analysis

    A. Sud, K. Hemminki, R. Houlston

    2015Hematological Oncology18 citations Open access

    Semantic Scholar

    Save

40. Whole genome sequencing of 2,023 colorectal cancers reveals mutational landscapes, new driver genes and immune interactions

    A. Cornish, Andreas J. Gruber, B. Kinnersley, D. Chubb +30 more

    2022bioRxiv16 citations Open access

    Semantic Scholar

    Save

41. Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes

    M. Went, B. Kinnersley, A. Sud, David C. Johnson +25 more

    2019Human Genomics16 citations Open access

    Semantic Scholar

    Save

42. A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC network study.

    K. Labrèche, M. Daniau, A. Sud, P. Law +73 more

    2019Neuro-Oncology15 citations Open access

    Semantic Scholar

    Save

43. Polygenic risk scores to stratify cancer screening should predict mortality not incidence

    A. Vickers, A. Sud, J. Bernstein, R. Houlston

    2022npj Precision Oncology13 citations Open access

    Semantic Scholar

    Save

44. Second cancer risk following Hodgkin lymphoma

    A. Sud, K. Hemminki, R. Houlston

    2017OncoTarget13 citations Open access

    Semantic Scholar

    Save

45. N-acetylcysteine with apocynin prevents hyperoxaluria-induced mitochondrial protein perturbations in nephrolithiasis

    Minu Sharma, A. Sud, Tanzeer Kaur, C. Tandon +1 more

    2016Free radical research13 citations

    Semantic Scholar

    Save

46. Genome-wide homozygosity signature and risk of Hodgkin lymphoma

    A. Sud, R. Cooke, A. Swerdlow, R. Houlston

    2015Scientific Reports13 citations Open access

    Semantic Scholar

    Save

47. Endocellulase Production by Cotylidia pannosa and its Application in Saccharification of Wheat Bran to Bioethanol

    D. Sharma, A. Sud, Saurabh Bansal, R. Mahajan +3 more

    2018Bioenergy Research12 citations

    Semantic Scholar

    Save

48. Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer

    A. Sud, Michael Jones, J. Broggio, S. Scott +17 more

    2020medRxiv11 citations Open access

    Semantic Scholar

    Save

49. Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients

    G. Zheng, S. Chattopadhyay, A. Sud, K. Sundquist +5 more

    2019Blood Cancer Journal11 citations Open access

    Semantic Scholar

    Save

50. Combined linkage and association analysis of classical Hodgkin lymphoma

    Alastair Lawrie, Shuo Han, A. Sud, Fay J. Hosking +7 more

    2018OncoTarget11 citations Open access

    Semantic Scholar

    Save